We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+13.33%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$54.8B
AUM Growth
+$4.24B
(+8.4%)
Cap. Flow
-$502M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
29.94%
Holding
1,776
New
37
Increased
449
Reduced
1,142
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$158M |
| 2 |
Uber
UBER
|
+$110M |
| 3 |
Blackstone Secured Lending
BXSL
|
+$97.3M |
| 4 |
Amazon
AMZN
|
+$76.3M |
| 5 |
PayPal
PYPL
|
+$75.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$184M |
| 2 |
Crown Castle
CCI
|
+$173M |
| 3 |
CME Group
CME
|
+$125M |
| 4 |
Gilead Sciences
GILD
|
+$119M |
| 5 |
Amgen
AMGN
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.81% |
| 2 | Healthcare | 15.16% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Jackson Financial
JXN
$8.58B
| $1.53M | ﹤0.01% |
23,076
-1,164
| -5% | -$63.2K |
|
1052
Enpro
NPO
$6.42B
| $1.53M | ﹤0.01% |
9,043
-456
| -5% | -$70.8K |
|
1053
Valaris
VAL
$5.15B
| $1.53M | ﹤0.01% |
20,277
-1,023
| -5% | -$68.6K |
|
1054
EXL Service
EXLS
$5.48B
| $1.52M | ﹤0.01% |
47,941
-2,419
| -5% | -$75.2K |
|
1055
Verra Mobility
VRRM
$770M
| $1.52M | ﹤0.01% |
60,888
-3,072
| -5% | -$69.9K |
|
1056
First Financial Bankshares
FFIN
$5.07B
| $1.52M | ﹤0.01% |
46,232
-2,332
| -5% | -$71.6K |
|
1057
Credicorp
BAP
$31B
| $1.51M | ﹤0.01% |
8,900
| – | – |
|
1058
Bloomin' Brands
BLMN
$762M
| $1.51M | ﹤0.01% |
52,492
-2,648
| -5% | -$72K |
|
1059
Sonoco
SON
$5.83B
| $1.5M | ﹤0.01% |
25,994
-1,311
| -5% | -$74.8K |
|
1060
American Airlines Group
AAL
$10B
| $1.5M | ﹤0.01% |
97,835
-4,935
| -5% | -$71.6K |
|
|
BCPC
1061
Balchem Corp
BCPC
$5.26B
| $1.5M | ﹤0.01% |
9,676
-488
| -5% | -$72.4K |
|
|
WIRE
1062
DELISTED
Encore Wire Corp
WIRE
| $1.5M | ﹤0.01% |
5,699
-288
| -5% | -$65.3K |
|
1063
Merit Medical Systems
MMSI
$4.78B
| $1.5M | ﹤0.01% |
19,744
-996
| -5% | -$76.9K |
|
1064
Axcelis
ACLS
$3.61B
| $1.49M | ﹤0.01% |
13,366
-674
| -5% | -$80.3K |
|
1065
Silicon Laboratories
SLAB
$7.17B
| $1.49M | ﹤0.01% |
10,371
-2,243
| -18% | -$297K |
|
|
GTM
1066
ZoomInfo Technologies
GTM
$1.02B
| $1.49M | ﹤0.01% |
92,951
-4,689
| -5% | -$76.3K |
|
1067
Arcosa
ACA
$7.13B
| $1.49M | ﹤0.01% |
17,345
-875
| -5% | -$71.2K |
|
1068
TD Synnex
SNX
$20.6B
| $1.49M | ﹤0.01% |
13,139
-663
| -5% | -$68.9K |
|
1069
Advanced Energy
AEIS
$10.6B
| $1.49M | ﹤0.01% |
14,566
-735
| -5% | -$75K |
|
1070
Gildan
GIL
$9.61B
| $1.48M | ﹤0.01% |
38,800
| – | – |
|
1071
Penske Automotive Group
PAG
$14.8B
| $1.48M | ﹤0.01% |
9,129
-461
| -5% | -$70.4K |
|
1072
Southwest Gas
SWX
$6.67B
| $1.48M | ﹤0.01% |
19,382
-978
| -5% | -$63.4K |
|
1073
Piper Sandler
PIPR
$5.12B
| $1.48M | ﹤0.01% |
29,732
-1,500
| -5% | -$68.6K |
|
1074
Kilroy Realty
KRC
$4.63B
| $1.47M | ﹤0.01% |
40,431
-2,040
| -5% | -$75.3K |
|
1075
Power Integrations
POWI
$3.26B
| $1.47M | ﹤0.01% |
20,565
-78,125
| -79% | -$5.83M |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Ensign Peak Advisors held 1,776 positions worth $54.8B, up 8.4% from $50.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 5%. Ensign Peak Advisors opened 37 new positions and exited 51, leaving the 1,776-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2024 buy was Blackstone Secured Lending: 3,319,725 shares worth $103M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2024, an estimated $158M increase.
- Ensign Peak Advisors's biggest Q1 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $184M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $66.5M.
- Ensign Peak Advisors's ten largest holdings make up 30% of its $54.8B portfolio in Q1 2024.
- Ensign Peak Advisors opened 37 new positions and closed 51 in Q1 2024.
- Ensign Peak Advisors's portfolio value rose 8.4% quarter-over-quarter to $54.8B.
Based on Ensign Peak Advisors's 13F filing for Q1 2024, filed 14 May 2024.